Resume

STEPHANIE SORINE

Freelance Creative Director | HCP/Patient Copy Specialist | Medical Advertising Hall of Fame

MEET STEPHANIE
Uniquely accomplished and award-winning Medical Advertising Hall of Fame pharmaceutical creative director/copywriter in both the traditional and digital/social space: Pre-to-post launch, US/global, with an extensive range of therapeutic experience—adult and pediatric—including oncology, rare disease, diabetes, heart disease, neurodegenerative conditions, Alzheimer’s disease, migraine, autoimmune/viral skin conditions, medical aesthetics and devices, advanced eye disorders, and women’s health

SPECIALTIES
Stand-out creative/strategic solutions proven to consistently achieve clients’ goals and win awards | Broad expertise in digital content development | Experienced leadership in managing and jumping in with a cross-functional staff | Strong ability to collaborate with clients across professional, patient, caregiver, and consumer target audiences

EXPERIENCE
2011 to present: FREELANCE Creative Director Copy/HCP/Patient/Caregiver

Delivering an unconventional level of copy support for pitches, concepts, messaging, traditional (print), digital (web, email, CVAs, social), video, and whatever it takes, including med/legal submissions.

Area 23

  • DEPOMED NUCYNTA opioid pain management launch (HCP)

21Grams

  • DEXCOM diabetes glucose monitoring device (HCP)

Havas Health

  • NOVO NORDISK Sickle Cell Disease launch (HCP/DTC)
  • ViiV Health Brands HIV brands (HCP)
  • PFIZER (BAVENCIO) and GENENTECH (GAZYVA): Oncology launches (HCP/patient)

Wildtype Health

  • ASTRA ZENECA CALQUENCE launch of oncology indications (HCP)

Imre

  • ASTRA ZENECA BREZTRI for COPD (HCP/DTC)

McKinney

  • INDIVIOR SUBLOCADE for opioid use disorder (HCP)

HumanCare, IPG

  • MADRIGAL Pharmaceuticals, launch of REZDIFFRA for fatty liver disease (HCP)

Syneos Health

  • BIOMARIN Pharmaceuticals, MERZ Therapeutics, and NOVAN: rare diseases (HCP)

Evoke

  • BRISTOL MYERS SQUIBB CAR T cell therapies (HCP)

McCann Health

  • JANSSEN XARELTO (HCP) cardiovascular disease

Wunderman Thompson

  • ALEXION, ASTRA ZENECA Rare Disease launch of KOSELUGO (HCP/patient)

GSW

  • CELGENE OTEZLA psoriasis and psoriatic arthritis (HCP)

BLOC

  • ASTRA ZENECA FARXIGA diabetes (HCP)
  • REGENERON EYLEA for age-related macular degeneration (HCP)

2017 to 2018: CultHealth (SVP, Creative Director, full-time)
Leading, managing, mentoring, and writing for:

  • ARRAY helped win oncology launch of BRAFTOVI + MEKTOVI advanced melanoma therapy
  • AMAG INTRAROSA dyspareunia treatment to improve sexual health
  • NOVO NORDISK helped launch OZEMPIC diabetes treatment

2015 to 2017: Area 23 | An FCB Health Company (VP, Associate Creative Director, full-time)
Leading, managing, mentoring, and writing for:

  • ABBVIE GLOBAL VIEKIRAX chronic hepatitis C treatment
  • LILLY SOLANEZUMAB Alzheimer’s drug and AMYVID Alzheimer’s diagnostic PET scan

2003 to 2011: RosettaWishbone (SVP, Senior Creative Director-Copy to Associate Partner, full-time)

As a key member of Wishbone’s Leadership Team, instrumental in helping to turn this project shop into one of the most highly acclaimed AOR pharmaceutical advertising agencies in the industry: Agency on the Rise 2004, Agency of the Year 2009 and acquisition by Rosetta Marketing.

  • OTSUKA helped win global launch of SAMSCA for hyponatremia—achieved first pharma brand on the iPAD (Trailblazer award, MM&M finalist for Best Interactive Initiative for HCPs, RxClub Excellence Award), MM&M finalist-Best Overall Professional Print Campaign for HN Disruption Advertorial Series, and Breathtek H. pylori urea breath test (Manny finalist-Best Medical Device Campaign)
  • NOVARTIS helped win the antihypertensive franchise, including: DIOVAN, EXFORGE, and the launch of VALTURNA
  • GENZYME helped win re-launch of SYNVISC viscosupplement (SILVER RX Club Award, PMT, MM&M, and 2019 Medical Advertising Hall of Fame Heritage award) and SEPRAFILM adhesion barrier, as well as the launch of SYNVISC ONE and KYNAMRO for familial hypercholesterolemia.
  • MEDA helped win re-launch of ZOMIG migraine therapy (achieved the Gold PMT Reader’s Choice Award for Faster than Fast concept, MM&M Best Product ad, SILVER RX Club, and 2018 Medical Advertising Hall of Fame Heritage Award) and OPTIVAR (PM 360 award and Pharma Choice).
  • DEY L.P. EPIPEN epinephrine (Rx CLUB, SILVER MM&M and PMT award winners), ACCUNEB pediatric asthma therapy, launch of COPD therapy, PERFOROMIST, and CYANOKIT cyanide antidote.
  • GSK helped win COMMIT stop smoking aid (Rx CLUB, SILVER IN-AWE, MM&M, GSK Pyramid)
  • ABBOTT helped win Wishbone’s 1st billion product and re-launch DEPAKOTE
  • RELIANT helped win launch of ANTARA fenofibrate
  • SIGMA-TAU helped win re-launch MATULANE oncology therapy
  • AUXILIUM helped win TESTIM testosterone therapy
  • SANOFI-AVENTIS/BMS PLAVIX projects (Rx CLUB award)
  • CARDIONET MCOT heart monitors (BRONZE PM 360 and SILVER MM&M)
  • SUCAMPO re-launch RESCULA glaucoma therapy

AWARDS and HONORS

  • CLIO, International Advertising Festival of New York including “bronze” for radio, Nabisco Marketing Excellence Award, MM&M Ad of the Year, Ad Council (Childhood Immunization), NAMA, GLOBALS, Rx Club including “silvers”, PMT GOLD, SmithKline Beecham’s Simply the Best and Pyramid awards, P&G Health Care Achievement Awards, Bronze Pharma Choice, Silver IN AWE, numerous Manny finalists
  • Featured in several Who’s Who including Emerging Leaders and Distinguished Individuals
  • HBA Rising Star
  • Work highlighted in MEDICINE AVENUE, by the MEDICAL ADVERTISING HALL OF FAME
  • MEDICAL ADVERTISING HALL OF FAME Heritage Award for ZOMIG Campaign
  • MEDICAL ADVERTISING HALL OF FAME Heritage Award for SYNVISC Campaign


EDUCATION

  • Royal Ballet School in England, Hunter College, School of Visual Arts